Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR 29,000
-600 (-2.03%)
Oct 31, 2025, 3:30 PM IST
Abbott India Employees
Abbott India had 3,659 employees as of March 31, 2025. The number of employees decreased by 155 or -4.06% compared to the previous year.
Employees
3,659
Change (1Y)
-155
Growth (1Y)
-4.06%
Revenue / Employee
18.01M INR
Profits / Employee
3.97M INR
Market Cap
616.30B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 3,659 | -155 | -4.06% |
| Mar 31, 2024 | 3,814 | 114 | 3.08% |
| Mar 31, 2023 | 3,700 | 103 | 2.86% |
| Mar 31, 2022 | 3,597 | 12 | 0.33% |
| Mar 31, 2021 | 3,585 | 34 | 0.96% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sun Pharmaceutical Industries | 43,000 |
| Apollo Hospitals Enterprise | 42,497 |
| Cipla | 30,313 |
| Zydus Lifesciences | 27,917 |
| Aurobindo Pharma | 27,707 |
| Mankind Pharma | 26,978 |
| Alkem Laboratories | 18,785 |
| Glenmark Pharmaceuticals | 15,800 |
Abbott India News
- 9 months ago - Abbott India shares surge 3% as net profit jumps 16% YoY to Rs 360.8 crore in Q3 - Business Upturn
- 10 months ago - Pharma stocks: Glenmark up 1.57%, Glaxo gains 1.31%, Mankind Pharma declines 2.84% - Business Upturn
- 10 months ago - Pharma Stocks Today: Biocon surges 4.41%, Mankind Pharma up 1.85%; Glaxo and Abbott India decline - Business Upturn
- 10 months ago - Stock Market Update, January 7: Apollo Hospitals, Apar Industries, Abbott India, Amber Enterprises and more hit 52-week highs today - Business Upturn
- 11 months ago - Pharma Stocks: Cipla down nearly 2%, Ajanta Pharma down 1.45%, Abbott India up 1.27% - Business Upturn
- 1 year ago - Abbott India launches 14-Valent Pneumococcal Conjugate vaccine offering broad protection for children - Business Upturn
- 1 year ago - Abbott India shares fall nearly 4% following Q2 results - Business Upturn
- 1 year ago - Abbott India Q2 FY25 Results: Revenue up 9.3% YoY to ₹1,632.67 crore, Net Profit rises 14.6% YoY - Business Upturn